Brind.

Nasdaq added Moderna to its Nasdaq-100 index, and Moderna combined its vaccine with Merck's drug.

1 report, 1 independent Updated 00:00

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Moderna Nasdaq Merck KGaA

Keep exploring

The entities involved

Moderna
American biotechnology company
- Moderna and Merck reported a landmark result from their melanoma study, while SanDisk and Dell were discussed in stock market analysis.06:35
- Moderna's stock gains are being driven by FDA approval and the broader growth of AI businesses, as a Nasdaq constituent.Sat 14:42
Nasdaq
American fully electronic stock exchange
- Kratos Defense & Security Solutions is involved in market activities, with its stock price reflecting market confidence in technology, alongside testing autonomous technology for race logistics with Nasdaq and NASCAR.14:37
- Nano Dimension Ltd. began trading on the Nasdaq stock exchange.12:36
Merck KGaA
German multinational science and technology company
- Merck KGaA and ABVC BioPharma are competing for investment as healthcare companies.Fri 09:06
- Morgan Stanley reduced its price target on Merck KGaA while Manufacturers Life Insurance Company increased its holdings in the stock.Thu 01:59

Related events

Moderna, Pfizer, and Merck are part of a healthcare rotation story, with Moderna outperforming Pfizer in current stock gains.Thu 18:58

Coverage

Newest first; wire copies grouped

00:00fool.com